Sutisak Kitareewan
Department of Pharmacology
Dartmouth Medical School
Hanover
NH 03755
USA
Name/email consistency: high
- Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. Kitareewan, S., Roebuck, B.D., Demidenko, E., Sloboda, R.D., Dmitrovsky, E. J. Natl. Cancer Inst. (2007)
- UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Kitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C.H., Nemeth, M.J., Golub, T.R., Freemantle, S.J., Dmitrovsky, E. Proc. Natl. Acad. Sci. U.S.A. (2002)